TRICARE, VA and GLP-1s in 2026: Coverage vs. Cash-Pay Telehealth
Price verification — October 26, 2026
This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.
- Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
- Zepbound (tirzepatide): LillyDirect self-pay: 2.5 mg starts at $299/28 days, 5 mg at $399, and 7.5 mg and above at $449 only with qualifying 45-day refill timing. Higher-dose prices can be higher when those conditions are not met. Supplies may cost extra. Official source
- Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
- Sesame annual-commitment terms: Official source.
These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.
Whether military coverage pays for your GLP-1 in 2026 depends on which plan you have and why the drug is prescribed. TRICARE Prime and Select can still cover weight-loss GLP-1s with prior authorization, but TRICARE For Life and direct care-only beneficiaries lost that coverage on Aug. 31, 2025, while GLP-1s for diabetes stay covered across TRICARE. VA care runs on its own criteria, and cash-pay telehealth mostly fills the gaps those rules leave.
Key takeaways
- Since Aug. 31, 2025, TRICARE For Life and direct care-only beneficiaries have had no TRICARE coverage for GLP-1s prescribed for weight loss.
- TRICARE Prime, Select and several other plans can still cover Wegovy and Zepbound with prior authorization, and the criteria are strict.
- In a June 30, 2026 Q&A, TRICARE said eligible beneficiaries living overseas can get weight-loss GLP-1s covered through a defined prior authorization route.
- Manufacturer copay cards exclude government beneficiaries, so those commercial savings cards are not an option on TRICARE. Self-pay programs have their own terms.
- VA pharmacies generally fill only prescriptions written within VA care, so a private telehealth prescription usually means paying cash.
What changed for TRICARE in 2025
On Aug. 5, 2025, TRICARE announced that the Defense Health Agency was adding regulatory controls on weight-loss medication coverage effective Aug. 31, 2025. Beneficiaries with TRICARE For Life and those with direct care-only access were excluded, and previously approved weight-loss prior authorizations for those groups were no longer valid, according to the TRICARE newsroom.
The same notice says GLP-1 drugs for diabetes remain covered for all patients with a diabetes diagnosis when medically necessary and prior authorization requirements are met, with no change to cost-shares.
The Military Officers Association of America's FAQ on the change lists the weight-loss drugs TFL beneficiaries now pay 100% for (Wegovy, Zepbound, Saxenda, Qsymia, phentermine and Contrave) and confirms that Ozempic, Mounjaro and Victoza remain covered for TFL beneficiaries with type 2 diabetes. It names TRICARE Prime, Select, Young Adult, Reserve Select, Retired Reserve and the Continued Health Care Benefit Program as not affected.
Who can still get coverage, plan by plan
| Your coverage | GLP-1 for weight loss | GLP-1 for type 2 diabetes |
|---|---|---|
| TRICARE Prime or Select (U.S.) | Possible with prior authorization | Covered when medically necessary, with PA |
| TRICARE Young Adult, Reserve Select, Retired Reserve, CHCBP | Not affected by the 2025 change; PA rules apply | Covered when medically necessary, with PA |
| TRICARE For Life | Not covered since Aug. 31, 2025 | Still covered |
| Direct care-only | Not covered since Aug. 31, 2025 | Still covered |
| TRICARE plans overseas | May be covered for eligible beneficiaries, with PA (per June 30, 2026 Q&A) | Covered when medically necessary, with PA |
| VA health care | Through VA clinicians under VA criteria | Through VA clinicians |
Source: TRICARE newsroom (Aug. 2025), MOAA FAQ, TRICARE overseas Q&A (June 2026). Always confirm a specific drug in the TRICARE Formulary Search Tool.
What TRICARE's prior authorization asks for
A TRICARE prior authorization request form for Wegovy and Zepbound, in the version used by Martin's Point Health Care's US Family Health Plan (the form is undated, and other TRICARE plans process requests through Express Scripts), shows how high the bar is. For adults, its weight-management criteria include:
- A BMI of 30 or higher, or 27 to 29 with at least one listed weight-related condition (such as hypertension, dyslipidemia, sleep apnea or established cardiovascular disease).
- At least 6 months of behavioral modification and dietary restriction, documented in the medical record, without reaching the desired weight loss.
- A 3-month trial of an older generic weight-loss drug such as phentermine without at least 5% weight loss, unless there is a contraindication or a qualifying exception.
- A prescription from a TRICARE-authorized provider.
- No pregnancy, no concurrent GLP-1, and no personal or family history of medullary thyroid cancer or MEN 2.
Approval lasts 12 months. Renewal for adults requires at least 5% loss from baseline weight and ongoing lifestyle engagement. The form also has a separate Zepbound pathway for moderate to severe obstructive sleep apnea (AHI of 15 or more and BMI of 30 or more), and it covers Wegovy, not Zepbound, for ages 12 to 17. It states that non-FDA-approved uses, including diabetes, are not approved on this form; people with diabetes are pointed to diabetes-indicated GLP-1s instead.
The 2026 overseas update
On June 30, 2026, TRICARE announced that weight-loss medications, including GLP-1s, may be covered for overseas beneficiaries who meet eligibility requirements. Its Q&A names Wegovy, Saxenda, Victoza, Zepbound and Mounjaro and lists criteria including an obesity diagnosis, age and BMI requirements, evaluation by a TRICARE network provider, and participation in a weight management plan.
How you fill it depends on where you are. At a military pharmacy or a network pharmacy in a U.S. territory, prior authorization runs through Express Scripts. At a host-nation retail pharmacy, you pay the full cost up front and file a claim with International SOS. Approval is valid for 12 months, after which you must requalify.
Not covered under your plan?
Compare how cash-pay providers describe their licensing, pharmacies and total monthly cost.
Paid links. We may earn a commission; it never changes what we write. See all options. Compounded medications are not FDA-approved.
How the VA handles GLP-1s
VA care is separate from TRICARE. VA clinicians decide on GLP-1 prescriptions under VA's own national formulary and criteria, which can differ from TRICARE's and from commercial plans. If you get care through VA, ask your VA primary care team whether you meet the current criteria for a weight-management GLP-1 before paying elsewhere.
Costs are low once you qualify. For 2026, VA brand-name (Tier 3) prescriptions cost $11 for a 1 to 30 day supply, medication copays stop after $700 in a calendar year, and Priority Group 1 veterans, including those rated 50% or more service-connected, pay no medication copays, per VA copay rates.
VA also offers its own telehealth. VA Video Connect lets enrolled veterans meet VA providers by video on a phone, tablet or computer, for care that does not need a hands-on exam. If your obstacle is travel rather than eligibility, that may solve it without leaving VA.
What VA generally will not do is fill a prescription from your private telehealth clinician. Under 38 CFR 17.96, VA fills prescriptions from non-VA doctors outside authorized VA care only for narrow groups, such as certain housebound veterans or those receiving aid and attendance benefits.
When cash-pay telehealth actually fills the gap
Paying cash makes the most sense in a few situations:
- You have TRICARE For Life or direct care-only access and want a GLP-1 for weight, not diabetes.
- You are on Prime or Select but do not meet the prior authorization criteria, or were denied on renewal.
- You use VA care but do not meet VA criteria, or prefer a non-VA prescriber and accept that the drug will be self-paid.
Before you pay, know the price you are comparing against. As of October 2026, Novo Nordisk's NovoCare self-pay page lists the Wegovy pill starting at $149 a month and the Wegovy pen at $349 a month for doses up to 2.4 mg, with an introductory $199 price on the two starting doses through Dec. 31, 2026. Lilly's Zepbound savings page lists self-pay KwikPen prices from $299 a month for the 2.5 mg dose, with 7.5 mg and higher doses at $449 under an offer that requires refilling within 45 days.
Two details matter for military families. Both manufacturers' commercial copay cards exclude government beneficiaries. And Lilly's self-pay card terms say you must not seek reimbursement for those costs from any third-party payer, including state or federal healthcare programs.
A note on TRICARE For Life and Medicare
The Medicare GLP-1 Bridge, which offers eligible people a $50 monthly copay through Dec. 31, 2027, runs through Medicare drug coverage. Medicare.gov lists the qualifying coverage types as standalone Part D plans, Medicare Advantage plans with drug coverage, Special Needs Plans, employer group waiver plans and the LI NET program. TRICARE For Life's pharmacy benefit is not on that list, so a TFL beneficiary without a Part D plan would not qualify. Medicare's open enrollment for joining a drug plan runs Oct. 15 to Dec. 7, with coverage starting Jan. 1, per Medicare.gov. Adding a Part D plan alongside TFL is a real coverage decision with trade-offs; talk to a TRICARE representative or your State Health Insurance Assistance Program before changing anything.
Check before you pay cash
| Question | Where to find the answer | What to do |
|---|---|---|
| Which TRICARE plan am I in? | Your enrollment card or milConnect | If Prime or Select, try prior authorization before paying cash |
| Is the drug for diabetes or weight? | Your diagnosis and the drug's indication | Diabetes-indicated GLP-1s remain covered with PA, including on TFL |
| Is the telehealth clinician TRICARE-authorized? | Ask the platform; check TRICARE's provider directory | If not, assume no TRICARE coverage for that prescription |
| Could VA cover it? | Your VA primary care team | Ask about criteria for use and VA Video Connect visits |
| Is the cash price for a brand or a compounded drug? | The platform's pharmacy and product details | Compare against manufacturer self-pay prices and ask what is FDA-approved |
Sources: TRICARE newsroom, TRICARE Wegovy/Zepbound PA form, 38 CFR 17.96.
A hypothetical, clearly labeled
Hypothetical scenario, not a real patient: A 68-year-old retiree on TRICARE For Life has a BMI of 33 and prediabetes. Because the prescription would be for weight, TRICARE will not cover it. VA criteria might apply if the retiree is enrolled in VA care. If not, the realistic choices are self-pay through a manufacturer program or a telehealth platform, or a separate look at whether a Part D plan and the Medicare Bridge make sense for the coming year. None of those choices should be made from an ad.
Where this guide stops
TRICARE and VA criteria change, and individual approvals depend on your records. This guide cannot tell you whether you qualify, which plan to choose, or whether a GLP-1 is right for you. For coverage questions, use the TRICARE Formulary Search Tool, Express Scripts, International SOS overseas, or your VA pharmacy. For medical questions, talk to your prescriber.
Paying out of pocket?
Compare participating providers, then verify each one's licensing, pharmacy and cancellation terms directly.
Paid links. We may earn a commission; it never changes what we write. See all options. Compounded medications are not FDA-approved.
Frequently asked questions
Does TRICARE For Life cover Wegovy or Zepbound for weight loss?
No. Since Aug. 31, 2025, TRICARE For Life and direct care-only beneficiaries have had no TRICARE coverage for GLP-1s prescribed for weight loss. GLP-1s prescribed for type 2 diabetes remain covered.
Can TRICARE Prime or Select still cover weight-loss GLP-1s?
Yes, with prior authorization. The TRICARE form requires BMI criteria, at least 6 months of documented lifestyle efforts, usually a trial of an older generic weight-loss drug, and a prescription from a TRICARE-authorized provider.
Will the VA fill a GLP-1 prescription from a private telehealth doctor?
Generally no. Under 38 CFR 17.96, VA fills prescriptions from non-VA doctors outside authorized VA care only for narrow groups, such as certain housebound veterans. Otherwise the prescription must come through VA care.
Can I use a manufacturer copay card if I have TRICARE?
The commercial copay cards for Wegovy and Zepbound exclude government beneficiaries. Self-pay programs are separate and come with their own terms, including not seeking reimbursement from federal programs.
Sources
- TRICARE: TRICARE Coverage of Weight Loss Medications: What To Know (Aug. 5, 2025)
- TRICARE: Q&A: Understanding TRICARE Coverage of Weight Loss Medications Overseas (June 30, 2026)
- MOAA: FAQ: TRICARE For Life and Weight-Loss Drugs
- TRICARE prior authorization request form for Wegovy/Zepbound, US Family Health Plan version (Martin's Point Health Care, undated)
- VA: Current VA health care copay rates (2026)
- VA Mobile: VA Video Connect
- eCFR: 38 CFR 17.96, Prescriptions filled
- NovoCare: Wegovy coverage and self-pay pricing
- Eli Lilly: Zepbound coverage and savings
- Medicare.gov: Weight loss drugs (Medicare GLP-1 Bridge)
- Medicare.gov: Joining a plan
Medical disclaimer: This article is general information, not medical advice, and does not replace a licensed clinician who knows your history. Approvals, labels, coverage and prices change; check the linked sources and talk with your prescriber or pharmacist before making decisions about any medication.